DEXYDERM

Serial Number 88320203
606

Registration Progress

Application Filed
Feb 28, 2019
Under Examination
Feb 18, 2020
Approved for Publication
Dec 24, 2019
Published for Opposition
Dec 24, 2019
Registered

Trademark Image

DEXYDERM

Basic Information

Serial Number
88320203
Filing Date
February 28, 2019
Published for Opposition
December 24, 2019
Abandonment Date
March 27, 2023
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Mar 27, 2023
Classes
005

Rights Holder

Teikoku Pharma USA, Inc.

03
Address
1718 Ringwood Avenue
San Jose, CA 951311711

Ownership History

Teikoku Pharma USA, Inc.

Original Applicant
03
San Jose, CA

Teikoku Pharma USA, Inc.

Owner at Publication
03
San Jose, CA

Legal Representation

Attorney
Bret E. Field

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

38 events
Date Code Type Description Documents
Mar 27, 2023 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Mar 27, 2023 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Aug 23, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 22, 2022 EX5G S SOU EXTENSION 5 GRANTED Loading...
Aug 22, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Aug 12, 2022 EXT5 S SOU EXTENSION 5 FILED Loading...
Aug 12, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 15, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 11, 2022 EXT4 S SOU EXTENSION 4 FILED Loading...
Feb 11, 2022 EX4G S SOU EXTENSION 4 GRANTED Loading...
Feb 11, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 17, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 13, 2021 EX3G S SOU EXTENSION 3 GRANTED Loading...
Aug 13, 2021 EXT3 S SOU EXTENSION 3 FILED Loading...
Aug 13, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 11, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 9, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Feb 9, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
Feb 9, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 13, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 11, 2020 EX1G S SOU EXTENSION 1 GRANTED Loading...
Aug 11, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 11, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 18, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 24, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 24, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 4, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 18, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 18, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 18, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 12, 2019 ALIE A ASSIGNED TO LIE Loading...
Nov 5, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 9, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 9, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
May 9, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 9, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 20, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 4, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Transdermal patches for use in the treatment of attention deficit hyperactivity disorder, anxiety insomnia, or substance withdrawal syndromes; transdermal patches for use in the management of pain; and transdermal patches for use in providing sedation, namely, sedatives, anaesthetics, general anesthetics, anesthetic for surgical use, anesthetics for non-surgical use; Pharmaceutical preparations, namely, topical preparations for use in the treatment of attention deficit hyperactivity disorder; Pharmaceutical preparations, namely, topical preparations for use in the treatment of anxiety; Pharmaceutical preparations, namely, topical preparations for use in the treatment of insomnia; Pharmaceutical preparations, namely, topical preparations for use in the treatment of substance withdrawal syndromes; Pharmaceutical preparations, namely, topical preparations for use in the management of pain; Pharmaceutical preparations, namely, topical preparations for use in providing sedation, namely, sedatives, anaesthetics, general anesthetics, anesthetic for surgical use, anesthetics for non-surgical use

Additional Information

Pseudo Mark
DEXY DERM

Classification

International Classes
005